This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Journal: Addiction (2019)
Authors: J.J.Q Zhang, K.N.K Fong, R.G Ouyang, A.M.H Siu, G.S Kranz
rTMS is increasingly used as an intervention for treating substance dependence.
The authorsaimed to assess evidence of the anti-craving and consumption-reducing effects of rTMS in patients with alcohol, nicotine, and illicit drug dependence.
A systematic review and meta-analysis of 26 randomized controlled trRCTs) published from January 2000 to October 2018 that investigated the effects of rTMS on craving and substance consumption in patients with nicotine, alcohol and illicit drug dependence (n = 748). Craving, measured using self-reported questionnaires or visual analogue scale, and substance consumption, measured using self-report substance intake or number of addiction relapse cases, were considered as primary and secondary outcomes, respectively. Substance type, study design, and rTMS parameters were used as the independent factors in the metaregression
Results showed that excitatory rTMS of the left dorsolateral prefrontal cortex (DLPFC) significantly reduced craving (Hedges’ g = -0.62; 95% CI, -0.89 to -0.35; P < 0.0001), compared with sham stimulation. Moreover, meta-regression revealed a significant positive association between the total number of stimulation pulses and effect size among studies using excitatory left DLPFC stimulation (P = 0.01). Effects of other rTMS protocols on craving were not significant. However, when examining substance consumption, excitatory rTMS of the left DLPFC and excitatory deep TMS (dTMS) of the bilateral DLPFC and insula revealed significant consumption-reducing effects, compared with sham stimulation.
Excitatory repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex appears to have an acute effect on reducing craving and substance consumptionin patients with substance dependence. The anti-craving effect may be associated with stimulation dose.